Na Zhu

RRP9 promotes gemcitabine resistance in pancreatic cancer via activating AKT signaling pathway

D. Qi, Zhiquan Liu, Ming Cheng, 2022, Cell Communication and Signaling.

Pleckstrin 2 is a potential drug target for colorectal carcinoma with activation of APC/β-catenin

Zhuowei Zhang, J. Jia, Xiaolong Cui, 2021, Molecular medicine reports.

Pr-modified vanadia-based catalyst for simultaneous elimination of NO and chlorobenzene

Pengpeng Xu, Na Zhu, Shuai Wang, 2023, Molecular Catalysis.